maalox 200mg/175mg per 5ml oral suspension
opella healthcare france sas t/a sanofi - magnesium hydroxide; aluminium hydroxide - oral suspension - 200mg/175 mg/5ml - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations
relcer tablets
glenmark pharmaceuticals kenya limited 6915-00200 nairobi - aluminium hydroxide gel usp (paste) magnesium - tablet - aluminium hydroxide gel usp e.q to aluminium - antacids with antiflatulents
polycrol gel
nicholas laboratories - dimeticone aluminium hydroxide magnesium hydroxide - gel
magnesium trisilicate compound tablet bp
sunward pharmaceutical private limited - aluminium hydroxide gel dried; magnesium trisilicate - tablet - 120 mg - aluminium hydroxide gel dried 120 mg; magnesium trisilicate 250 mg
magnesium sulfate heptahydrate injection solution
x-gen pharmaceuticals, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml
alutril forte 500 mg/250 mg chewable tablets
remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - magnesium trisilicate, aluminium hydroxide - chewable tablet - magnesium trisilicate 500 mg aluminium hydroxide 250 mg - drugs for acid related disorders
magnesium sulfate- magnesium sulfate heptahydrate injection, solution
remedyrepack inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.
barexal 3 g - 0.125 g or. susp. (pwdr.) sachet
ipsen sa-nv - smectite dioctaed 3000 mg; aluminium hydroxide-magnesium carbonate coprecipitate 125 mg - powder for oral suspension - smectite dioctaed 3000 mg; aluminium hydroxide-magnesium carbonate 125 mg - diosmectite
antagit ds gel mint flavour 400mg + 400mg + 50mg oral liquid ordinary suspensions
leben laboratories ltd - dried aluminium hydroxide + magnesium hydroxide + simethicone - oral liquid ordinary suspensions - 400mg + 400mg + 50mg
propan gel s
adcock ingram ltd - aluminium hydroxide gel , magnesium oxide light, dicyclomine hydrochloride , simethicone - suspension - each 10 ml suspension contains: aluminium hydroxide gel equiv. to aluminium oxide 200 mg, magnesium oxide light 200 mg, dicyclom